BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test Read more →
Fierce Biotech Fundraising Tracker '26: AusperBio adds $120M; Abcuro secures $66M Read more →
AusperBio adds $120M series C to advance hep B oligo therapy through phase 3 and beyond Read more →
